This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Guacetisal" – news · newspapers · books · scholar · JSTOR (November 2023) (Learn how and when to remove this message) |
Clinical data | |
---|---|
Trade names | Broncaspin; Balsacetil; Guaiaspir; Prontomucil |
Other names | Aspirin guaiacol ester; O-Methoxyphenyl salicylate acetate |
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.054.221 |
Chemical and physical data | |
Formula | C16H14O5 |
Molar mass | 286.283 g·mol |
3D model (JSmol) | |
Melting point | 72 to 74.5 °C (161.6 to 166.1 °F) |
SMILES
| |
InChI
|
Guacetisal is a drug that has been used to treat inflammatory respiratory diseases. Chemically, it is an ester resulting from the combination of aspirin and guaiacol.
References
- Vizioli A, Zamperini D, Ursaia G (December 1982). "". La Clinica Terapeutica. 103 (5): 527–33. PMID 6761043.
Non-steroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA) | |
---|---|
pyrazolones / pyrazolidines | |
salicylates | |
acetic acid derivatives and related substances | |
oxicams | |
propionic acid derivatives (profens) |
|
n-arylanthranilic acids (fenamates) | |
COX-2 inhibitors (coxibs) | |
other | |
NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; WHO-Essential Medicines; withdrawn drugs; veterinary use. | |
This drug article relating to the respiratory system is a stub. You can help Misplaced Pages by expanding it. |